Comparison |
Alternate Manufacturer Number |
3567708 | 2008134 | 2069276 | 3760550 | |
Container Type |
Bottle | Bottle | Bottle | Bottle | Single-Dose Kit |
Country of Origin |
Unknown | United States | Unknown | Ireland | Unknown |
Dosage Form |
Tablet | Tablet | Tablet | Tablet | Injection |
Generic Drug Code |
| 31095 | 35079 | 44426 | |
Generic Drug Name |
Dolutegravir Sodium | Raltegravir Potassium | Dolutegravir Sodium | Bictegravir Sodium / Emtricitabine / Tenofovir Alafenamide Fumarate | Cabotegravir |
NDC Number |
49702022613 | 00006047761 | 49702022813 | 61958250101 | 49702026423 |
Quantity |
30 Tablets | 60 Tablets | 30 Tablets | 30 Tablets | |
Storage Requirements |
| | | | Requires Refrigeration |
Strength |
10 mg | 100 mg | 50 mg | 50 mg - 200 mg - 25 mg | 600 mg / mL |
Type |
| Unit of Use, Chewable | | | Intramuscular |
UNSPSC Code |
51343204 | 51343201 | 51343204 | 51343800 | 51343700 |
Volume |
| | | | 3 mL |
Application |
HIV Integrase Inhibitor | HIV Integrase Inhibitor | HIV Integrase Inhibitor | HIV Integrase Inhibitor | HIV Integrase Inhibitor |
Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
Features and Benefits |
|
|
- TIVICAY is a prescription medicine that is used together with other antiretroviral medicines to treat Human Immunodeficiency Virus (HIV‑1) infection in adults and children who weigh at least 66 pounds
- Film Coated
|
|
- Cabotegravir extended-release injectable suspension
- For gluteal intramuscular use only
- Indicated in at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1 infection
- Contents: 1 Single-dose vial, 1 Vial Adapter, 1 Syringe, 1 Injection needle (23 gauge, 1-1/2 Inch)
|